Bipolar disorder is linked to an increased risk of suicide and is treated with a range of different drugs. Lithium has been suggested to be superior to other drugs in preventing suicide by a number of RCTs. The study population in these studies has, however, been restricted and findings might not be representative of all persons with bipolar disorder. Therefore, naturalistic studies with larger sample sizes are needed. This study will use Danish National registers to compare treatment effects of lithium to that of other moodstabilisers and antipsychotics.
The study is supported by the Lundbeck Foundation.
- Prof Keith Hawton, Centre for Suicide Research, University of Oxford
- Michael Eriksen Benros, Psykiatrisk Center København